• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TRIM59 通过激活 STAT3 促进骨肉瘤进展。

TRIM59 promotes osteosarcoma progression via activation of STAT3.

机构信息

Department of Orthopaedics, Jiading District Anting Hospital of Shanghai, Shanghai, 201805, China.

Shanghai Key Laboratory of Orthopaedic Implant, Department of Orthopaedics, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China.

出版信息

Hum Cell. 2022 Jan;35(1):250-259. doi: 10.1007/s13577-021-00615-y. Epub 2021 Oct 9.

DOI:10.1007/s13577-021-00615-y
PMID:34625908
Abstract

Osteosarcoma (OS) is a common, highly malignant bone tumor. Tripartite motif-containing protein 59 (TRIM59) has been identified as a potential oncogenic protein involved in the initiation and progression of various human carcinomas. Nonetheless, the possible roles and molecular mechanisms of action of TRIM59 in OS remain unclear. In this study, we found that TRIM59 expression levels were frequently upregulated in OS tissues and cell lines. TRIM59 knockdown significantly suppressed the proliferation, migration, and invasion of OS cells and promoted OS cell apoptosis, whereas TRIM59 overexpression had the opposite effects. In vivo experiments demonstrated that TRIM59 knockdown suppressed OS tumor growth and metastasis in vivo. Furthermore, we found that TRIM59 directly interacted with phospho-STAT3 in OS cells. The downregulation of STAT3 levels attenuated TRIM59-induced cell proliferation and invasion. Taken together, our results indicate that TRIM59 promoted OS progression via STAT3 activation. Therefore, our study may provide a novel therapeutic target for OS.

摘要

骨肉瘤(OS)是一种常见的高度恶性骨肿瘤。三结构域蛋白 59(TRIM59)已被鉴定为一种潜在的致癌蛋白,参与各种人类癌的发生和进展。然而,TRIM59 在 OS 中的可能作用和分子机制尚不清楚。在本研究中,我们发现 TRIM59 表达水平在 OS 组织和细胞系中经常上调。TRIM59 敲低显著抑制 OS 细胞的增殖、迁移和侵袭,并促进 OS 细胞凋亡,而 TRIM59 过表达则有相反的效果。体内实验表明,TRIM59 敲低抑制了体内 OS 肿瘤的生长和转移。此外,我们发现 TRIM59 直接与 OS 细胞中的磷酸化 STAT3 相互作用。STAT3 水平的下调减弱了 TRIM59 诱导的细胞增殖和侵袭。总之,我们的研究结果表明,TRIM59 通过激活 STAT3 促进 OS 的进展。因此,我们的研究可能为 OS 提供了一个新的治疗靶点。

相似文献

1
TRIM59 promotes osteosarcoma progression via activation of STAT3.TRIM59 通过激活 STAT3 促进骨肉瘤进展。
Hum Cell. 2022 Jan;35(1):250-259. doi: 10.1007/s13577-021-00615-y. Epub 2021 Oct 9.
2
TRIM59 is upregulated and promotes cell proliferation and migration in human osteosarcoma.TRIM59在人骨肉瘤中表达上调,并促进细胞增殖和迁移。
Mol Med Rep. 2016 Jun;13(6):5200-6. doi: 10.3892/mmr.2016.5183. Epub 2016 Apr 25.
3
LncRNA BLACAT1 accelerates the proliferation and migration of osteosarcoma cells through regulating STAT3.长链非编码RNA BLACAT1通过调控信号转导和转录激活因子3(STAT3)促进骨肉瘤细胞的增殖和迁移。
Pathol Res Pract. 2019 Mar;215(3):571-579. doi: 10.1016/j.prp.2019.01.017. Epub 2019 Jan 14.
4
LncRNA-PVT1 Inhibits Ferroptosis through Activating STAT3/GPX4 Axis to Promote Osteosarcoma Progression.长链非编码RNA-PVT1通过激活STAT3/GPX4轴抑制铁死亡以促进骨肉瘤进展。
Front Biosci (Landmark Ed). 2024 May 30;29(6):207. doi: 10.31083/j.fbl2906207.
5
MiR-501-3p promotes osteosarcoma cell proliferation, migration and invasion by targeting BCL7A.miR-501-3p 通过靶向 BCL7A 促进骨肉瘤细胞的增殖、迁移和侵袭。
Hum Cell. 2021 Mar;34(2):624-633. doi: 10.1007/s13577-020-00468-x. Epub 2021 Jan 7.
6
Tripartite motif containing 59 (TRIM59) promotes esophageal cancer progression via promoting MST4 expression and ERK pathway.三结构域蛋白 59(TRIM59)通过促进 MST4 表达和 ERK 通路促进食管癌的进展。
J Recept Signal Transduct Res. 2020 Oct;40(5):471-478. doi: 10.1080/10799893.2020.1756327. Epub 2020 Apr 27.
7
TRIM59 Promotes Retinoblastoma Progression by Activating the p38-MAPK Signaling Pathway.TRIM59 通过激活 p38-MAPK 信号通路促进视网膜母细胞瘤的进展。
Invest Ophthalmol Vis Sci. 2020 Aug 3;61(10):2. doi: 10.1167/iovs.61.10.2.
8
TRIM59 predicts poor prognosis and promotes pancreatic cancer progression via the PI3K/AKT/mTOR-glycolysis signaling axis.TRIM59 通过 PI3K/AKT/mTOR 糖酵解信号通路预测不良预后并促进胰腺癌进展。
J Cell Biochem. 2020 Feb;121(2):1986-1997. doi: 10.1002/jcb.29433. Epub 2019 Nov 6.
9
Overexpression of miR-335 inhibits the migration and invasion of osteosarcoma by targeting SNIP1.miR-335 的过表达通过靶向 SNIP1 抑制骨肉瘤的迁移和侵袭。
Int J Biol Macromol. 2019 Jul 15;133:137-147. doi: 10.1016/j.ijbiomac.2019.04.016. Epub 2019 Apr 4.
10
Knockdown of CD44 inhibits proliferation, migration and invasion of osteosarcoma cells accompanied by downregulation of cathepsin S.敲低 CD44 抑制骨肉瘤细胞的增殖、迁移和侵袭,并伴随组织蛋白酶 S 的下调。
J Orthop Surg Res. 2022 Mar 9;17(1):154. doi: 10.1186/s13018-022-03048-x.

引用本文的文献

1
Targeting myeloid-derived suppressor cells in the tumor microenvironment: potential therapeutic approaches for osteosarcoma.靶向肿瘤微环境中的髓源性抑制细胞:骨肉瘤的潜在治疗方法
Oncol Res. 2025 Feb 28;33(3):519-531. doi: 10.32604/or.2024.056860. eCollection 2025.
2
Myeloid Cell Deficiency Worsens Experimental Ischemic Stroke and Alters Cerebral Proteomic Profile.髓样细胞缺乏会加重实验性缺血性中风并改变脑蛋白质组学图谱。
J Inflamm Res. 2024 Jul 19;17:4827-4843. doi: 10.2147/JIR.S469651. eCollection 2024.
3
TRIM8 promotes ovarian cancer proliferation and migration by targeting VDAC2 for ubiquitination and degradation.

本文引用的文献

1
STAT3 and its targeting inhibitors in osteosarcoma.STAT3 及其在骨肉瘤中的靶向抑制剂。
Cell Prolif. 2021 Feb;54(2):e12974. doi: 10.1111/cpr.12974. Epub 2020 Dec 31.
2
Androgen-dependent miR-125a-5p targets LYPLA1 and regulates global protein palmitoylation level in late-onset hypogonadism males.雄激素依赖性 miR-125a-5p 靶向 LYPLA1 并调节迟发性性腺功能减退症男性的全局蛋白棕榈酰化水平。
J Cell Physiol. 2021 Jun;236(6):4738-4749. doi: 10.1002/jcp.30195. Epub 2020 Dec 7.
3
Mesenchymal stem cells reverse EMT process through blocking the activation of NF-κB and Hedgehog pathways in LPS-induced acute lung injury.
TRIM8 通过靶向 VDAC2 进行泛素化和降解促进卵巢癌细胞增殖和迁移。
Cancer Med. 2024 Jun;13(11):e7396. doi: 10.1002/cam4.7396.
4
Protein Stability Regulation in Osteosarcoma: The Ubiquitin-like Modifications and Glycosylation as Mediators of Tumor Growth and as Targets for Therapy.骨肉瘤中蛋白质稳定性的调控:泛素样修饰和糖基化作为肿瘤生长的介质以及治疗的靶点。
Cells. 2024 Mar 18;13(6):537. doi: 10.3390/cells13060537.
5
A role of TRIM59 in pulmonary hypertension: modulating the protein ubiquitylation modification.TRIM59 在肺动脉高压中的作用:调节蛋白质泛素化修饰。
J Transl Med. 2023 Nov 17;21(1):821. doi: 10.1186/s12967-023-04712-4.
6
Intricate confrontation: Research progress and application potential of TRIM family proteins in tumor immune escape.错综复杂的对抗:TRIM 家族蛋白在肿瘤免疫逃逸中的研究进展与应用潜力。
J Adv Res. 2023 Dec;54:147-179. doi: 10.1016/j.jare.2023.01.011. Epub 2023 Feb 2.
间充质干细胞通过阻断 LPS 诱导的急性肺损伤中 NF-κB 和 Hedgehog 通路的激活来逆转 EMT 过程。
Cell Death Dis. 2020 Oct 15;11(10):863. doi: 10.1038/s41419-020-03034-3.
4
Exosomal Transfer of LCP1 Promotes Osteosarcoma Cell Tumorigenesis and Metastasis by Activating the JAK2/STAT3 Signaling Pathway.LCP1的外泌体转移通过激活JAK2/STAT3信号通路促进骨肉瘤细胞的肿瘤发生和转移。
Mol Ther Nucleic Acids. 2020 Sep 4;21:900-915. doi: 10.1016/j.omtn.2020.07.025. Epub 2020 Jul 23.
5
Heme Causes Pain in Sickle Mice Toll-Like Receptor 4-Mediated Reactive Oxygen Species- and Endoplasmic Reticulum Stress-Induced Glial Activation.亚铁血红素导致镰状细胞小鼠疼痛 通过 Toll 样受体 4 介导的活性氧和内质网应激诱导的神经胶质细胞激活
Antioxid Redox Signal. 2021 Feb 1;34(4):279-293. doi: 10.1089/ars.2019.7913. Epub 2020 Aug 24.
6
KIF18B promotes tumor progression in osteosarcoma by activating β-catenin.KIF18B 通过激活 β-catenin 促进骨肉瘤的肿瘤进展。
Cancer Biol Med. 2020 May 15;17(2):371-386. doi: 10.20892/j.issn.2095-3941.2019.0452.
7
TRIM59 attenuates IL-1β-driven cartilage matrix degradation in osteoarthritis via direct suppression of NF-κB and JAK2/STAT3 signaling pathway.TRIM59 通过直接抑制 NF-κB 和 JAK2/STAT3 信号通路来减轻骨关节炎中 IL-1β 驱动的软骨基质降解。
Biochem Biophys Res Commun. 2020 Aug 13;529(1):28-34. doi: 10.1016/j.bbrc.2020.05.130. Epub 2020 Jun 5.
8
TRIM59 inhibits PPM1A through ubiquitination and activates TGF-β/Smad signaling to promote the invasion of ectopic endometrial stromal cells in endometriosis.TRIM59 通过泛素化抑制 PPM1A,并激活 TGF-β/Smad 信号通路,促进子宫内膜异位症中异位子宫内膜基质细胞的侵袭。
Am J Physiol Cell Physiol. 2020 Aug 1;319(2):C392-C401. doi: 10.1152/ajpcell.00127.2019. Epub 2020 Apr 29.
9
TRIM59, amplified in ovarian cancer, promotes tumorigenesis through the MKP3/ERK pathway.TRIM59 在卵巢癌中扩增,通过 MKP3/ERK 通路促进肿瘤发生。
J Cell Physiol. 2020 Nov;235(11):8236-8245. doi: 10.1002/jcp.29478. Epub 2020 Jan 17.
10
TRIM59 promotes tumor growth in hepatocellular carcinoma and regulates the cell cycle by degradation of protein phosphatase 1B.TRIM59 通过降解蛋白磷酸酶 1B 促进肝癌肿瘤生长并调控细胞周期。
Cancer Lett. 2020 Mar 31;473:13-24. doi: 10.1016/j.canlet.2019.12.030. Epub 2019 Dec 23.